[Mmcap_list] FW: COVID-19 update: April 10 - Cardinal Healthcare - Pharmaceutical Distribution

[DOKE Lori * DAS]

Email below, including  attachments received from Cardinal Healthcare-Pharmaceutical Distribution.

Lori Doke, CPPB, OPBC, CTAC
State Procurement Analyst
DAS-EGS Procurement Services
C - (971)  719-1627

*****CONFIDENTIALITY NOTICE*****

This e-mail may contain information that is privileged, confidential, or otherwise exempt from disclosure under applicable law. If you are not the addressee or it appears from the context or otherwise that you have received this e-mail in error, please advise me immediately by reply e-mail, keep the contents confidential, and immediately delete the message and any attachments from your system.

************************************


From: Collett, Janine <janine.collett at cardinalhealth.com>
Sent: Monday, April 13, 2020 7:22 AM
To: Collett, Janine <janine.collett at cardinalhealth.com>
Cc: Leeker, Kim (ADM) <kim.leeker at state.mn.us>; Hankins, Kim (ADM) <kim.hankins at state.mn.us>
Subject: COVID-19 update: April 10

Dear Valued Customer,

In these unprecedented times, we reach out Monday through Friday with the latest information to keep you up-to-date. On April 1, 2020, the U.S. Food and Drug Administration released a Press Announcement<https://www.fda.gov/news-events/press-announcements/fda-requests-removal-all-ranitidine-products-zantac-market> requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. With the announcement, the FDA is sending letters to all manufacturers of ranitidine requesting they withdraw their products from the market. The FDA is also advising consumers taking OTC ranitidine to stop taking any tablets or liquid they currently have, dispose of them properly and not buy more.

Cardinal Health has stopped distribution of all ranitidine products and will communicate any official withdrawal notices and instructions from manufacturers as they are received. Please see attached Product Focus.
We have not added any new questions to our frequently asked questions and answers document today.

Thank you for everything you are doing to support your patients at this time. For the latest COVID-19 information, please visit www.cardinalhealth.com/covid19<http://www.cardinalhealth.com/covid19>.

Thank you for your partnership.







[http://wwwdmz.cardinalhealth.com/content/dam/corp/web/logos/CAH-logo-solutions.png]
Janine Collett
State Government Regional Leader
7000 Cardinal Place Dublin, OH. 43017
480.567.5713 mobile l 614.652.4644 fax
866.641.1199 Cust Svc



_________________________________________________

This message is for the designated recipient only and may contain privileged, proprietary
or otherwise private information. If you have received it in error, please notify the sender
immediately and delete the original. Any other use of the email by you is prohibited.

Dansk - Deutsch - Espanol - Francais - Italiano - Japanese - Nederlands - Norsk - Portuguese - Chinese
Svenska: http://www.cardinalhealth.com/en/support/terms-and-conditions-english.html
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://omls.oregon.gov/pipermail/mmcap_list/attachments/20200413/e75380be/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 8397 bytes
Desc: image001.png
URL: <https://omls.oregon.gov/pipermail/mmcap_list/attachments/20200413/e75380be/attachment.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: COVID-19 customer FAQs April 10_11.pdf
Type: application/pdf
Size: 201976 bytes
Desc: COVID-19 customer FAQs April 10_11.pdf
URL: <https://omls.oregon.gov/pipermail/mmcap_list/attachments/20200413/e75380be/attachment.pdf>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: Ranitidine product focus 4.10.2020 final.pdf
Type: application/pdf
Size: 77821 bytes
Desc: Ranitidine product focus 4.10.2020 final.pdf
URL: <https://omls.oregon.gov/pipermail/mmcap_list/attachments/20200413/e75380be/attachment-0001.pdf>